Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urogenital Neoplasms × aldesleukin × Clear all

Sponsor

Conditions

Melanoma 46 Neoplasm Metastasis 19 Skin Neoplasms 14 Carcinoma, Renal Cell 13 Leukemia, Myeloid, Acute 11 Kidney Neoplasms 10 Leukemia 9 Neoplasms 7 Uterine Cervical Neoplasms 5 Lymphoma 5 Congenital Abnormalities 5 Breast Neoplasms 5 Ovarian Neoplasms 4 Neuroblastoma 4 Carcinoma, Non-Small-Cell Lung 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Myelodysplastic Syndromes 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Vaginal Neoplasms 2 Penile Neoplasms 2 Papillomavirus Infections 2 Oropharyngeal Neoplasms 2 Melanoma, Experimental 2 Lymphoma, Mantle-Cell 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Erythroblastic, Acute 2 Brain Neoplasms 2

Interventions

Sunitinib 2 Paclitaxel 2 valrubicin 1 temsirolimus 1 sipuleucel-T 1 luprolide acetate gel depot 1 ferumoxtran-10 1 abiraterone 1 abemaciclib 1 Suspensions 1 Surveys and Questionnaires 1 Standard of Care 1 Radiotherapy 1 Prednisone 1 Prednisolone 1 Powders 1 Pemetrexed 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Leuprolide 1 Educational Status 1 Docetaxel 1 Bevacizumab 1 Administration, Intravesical 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡